UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

Blood, 2015-08, Vol.126 (9), p.1078-1085

2015

Volltextzugriff (PDF)

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

Blood, 2021-02, Vol.137 (6), p.763-774

2021

Volltextzugriff (PDF)

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

The New England journal of medicine, 2020-09, Vol.383 (11), p.1018-1027

2020

Volltextzugriff (PDF)

Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury

Blood, 2015-03, Vol.125 (13), p.2151-2159

2015

Volltextzugriff (PDF)

Diagnosis and management of thrombosis in pregnancy

Birth defects research. Part C. Embryo today, 2015-09, Vol.105 (3), p.185-189

Konkle, Barbara A.

2015

Volltextzugriff (PDF)

High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion

Blood, 2016-02, Vol.127 (5), p.637-645

2016

Volltextzugriff (PDF)

Cysteine Disulfides (Cys-ss-X) as Sensitive Plasma Biomarkers of Oxidative Stress

Scientific reports, 2019-01, Vol.9 (1), p.115-115, Article 115

2019

Volltextzugriff (PDF)

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-01, Vol.30 (1), p.214-223

2024

Volltextzugriff (PDF)

Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII

PloS one, 2020-05, Vol.15 (5), p.e0233576-e0233576

2020

Volltextzugriff (PDF)

Neurosurgical bleeding in platelet storage pool disorder: a case report

Platelets (Edinburgh), 2024-12, Vol.35 (1), p.2380374

2024

Volltextzugriff (PDF)

World Federation of Hemophilia Gene Therapy Registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-07, Vol.26 (4), p.563-564

2020

Volltextzugriff (PDF)

Depression and anxiety in persons with Von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.545-554

2023

Volltextzugriff (PDF)

The burden of heavy menstrual bleeding

Blood, 2022-10, Vol.140 (16), p.1747-1748

Konkle, Barbara A.

2022

Volltextzugriff (PDF)

Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy

PloS one, 2014-11, Vol.9 (11), p.e112935-e112935

2014

Volltextzugriff (PDF)

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

Blood advances, 2018-08, Vol.2 (16), p.2136-2144

2018

Volltextzugriff (PDF)

How I approach bleeding in hospitalized patients

Blood, 2023-08, Vol.142 (9), p.761-768

2023

Volltextzugriff (PDF)

Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative

Blood advances, 2017-05, Vol.1 (13), p.824-834

2017

Volltextzugriff (PDF)

Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A

Expert review of hematology, 2023-08, Vol.16 (8), p.567-573

Konkle, Barbara A

2023

Volltextzugriff (PDF)

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

American journal of obstetrics and gynecology, 2009-07, Vol.201 (1), p.12.e1-12.e8

2009

Volltextzugriff (PDF)

Site-Specific N- and O-Glycosylation Analysis of Human Plasma Fibronectin

Frontiers in chemistry, 2021-06, Vol.9, p.691217-691217

2021

Volltextzugriff (PDF)

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

The New England journal of medicine, 2023-01, Vol.388 (4), p.310-318

2023

Volltextzugriff (PDF)

Impacting inhibitor development in hemophilia A

Blood, 2017-10, Vol.130 (15), p.1689-1690

Konkle, Barbara A.

2017

Volltextzugriff (PDF)

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

Research and practice in thrombosis and haemostasis, 2021-05, Vol.5 (4), p.e12488-n/a, Article e12488

2021

Volltextzugriff (PDF)

Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations

International journal of hematology, 2017-11, Vol.106 (5), p.704-710

2017

Volltextzugriff (PDF)

A cross-sectional analysis of cardiovascular disease in the hemophilia population

Blood advances, 2018-06, Vol.2 (11), p.1325-1333

2018

Volltextzugriff (PDF)

1 – 25 von 405

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(282)
Mit Volltextzugriff
(258)

Publikationsform

Artikel
(296)
Buchkapitel
(106)
Bücher
(2)
Berichte
(1)

Sprache

Englisch
(404)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(176)
Life Sciences & Biomedicine
(157)
Humans
(145)
Hematology
(113)
Hematology, Oncology, And Palliative Medicine
(87)
Male
(60)
Female
(59)
Adult
(49)
Hemophilia
(44)
Biological And Medical Sciences
(40)
Middle Aged
(36)
Cardiovascular System & Cardiology
(32)
Medical Sciences
(31)
Peripheral Vascular Disease
(28)
Aged
(27)
Child
(23)
Genomes
(20)
Adolescent
(19)
Multidisciplinary Sciences
(18)
Science & Technology - Other Topics
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(38)

Menü

Weitere Dienste

Einstellungen

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A

Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury

Diagnosis and management of thrombosis in pregnancy

High-density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion

Cysteine Disulfides (Cys-ss-X) as Sensitive Plasma Biomarkers of Oxidative Stress

A global comparative field study to evaluate the factor VIII activity of efanesoctocog alfa by one‐stage clotting and chromogenic substrate assays at clinical haemostasis laboratories

Comparative glycosylation mapping of plasma-derived and recombinant human factor VIII

Neurosurgical bleeding in platelet storage pool disorder: a case report

World Federation of Hemophilia Gene Therapy Registry

Depression and anxiety in persons with Von Willebrand disease

The burden of heavy menstrual bleeding

Complex changes in von Willebrand factor-associated parameters are acquired during uncomplicated pregnancy

The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B

How I approach bleeding in hospitalized patients

Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative

Efanesoctocog alfa for the prevention and treatment of bleeding in patients with hemophilia A

Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel

Site-Specific N- and O-Glycosylation Analysis of Human Plasma Fibronectin

Efanesoctocog Alfa Prophylaxis for Patients with Severe Hemophilia A

Impacting inhibitor development in hemophilia A

Patient‐relevant health outcomes for hemophilia care: Development of an international standard outcomes set

Efficacy and safety of full-length pegylated recombinant factor VIII with extended half-life in previously treated patients with hemophilia A: comparison of data between the general and Japanese study populations

A cross-sectional analysis of cardiovascular disease in the hemophilia population

Suchergebnisse filtern